Purchases and Sales Made in Q3 2023 in Fulcrum Therapeutics, Inc. (FULC)
This table provides information about the institutional ownership of Fulcrum Therapeutics, Inc. (FULC) during Q3 2023. The information is specifically focused on institutions that hold shares of Fulcrum Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-73.3K- 12.31% |
$238K - $446K
|
522K
$1.85M
|
|
|
Nov 14, 2023
Q3 2023
|
Simplify Asset Management Inc.
New York, NY |
SELL
|
- |
-126K- 18.06% |
$409K - $765K
|
571K
$2.03M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-129K- 33.14% |
$418K - $781K
|
259K
$920K
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-192K- 17.39% |
$624K - $1.17M
|
912K
$3.24M
|
|
|
Nov 14, 2023
Q3 2023
|
Rtw Investments, LP
New York, NY |
SELL
|
- |
-245K- 4.05% |
$797K - $1.49M
|
5.82M
$20.7M
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-250K- 16.65% |
$814K - $1.52M
|
1.25M
$4.45M
|
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-292K- 84.71% |
$949K - $1.78M
|
52.7K
$187K
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-612K- 70.26% |
$1.99M - $3.72M
|
259K
$920K
|